Navigation Links
21st Congress of the College of Neuropsychopharmacology
Date:4/18/2008

From 30 August 3 September 2008 the 21st Congress of the European College of Neuropsychopharmacology (ECNP) will be held in Barcelona, Spain. This Congress is the largest annual meeting on psychopharmacology and mental disorders in Europe of a high scientific standard, attended by more than 6,000 participants (clinical and basic scientists such as psychiatrists, neurologists, psychologists and neuroscience researchers) from all over the world.

This years programme will present not only the latest findings and breakthroughs in neuropsychopharmacology and related disciplines in both preclinical and clinical settings, but also cover the various aspects of pharmacotherapy of brain disorders and their impact on the quality of life of patients with psychiatric and neurological disorders.

In this regard, the scientific programme will comprise, among others, the following topics:

  • Neurogenesis and stem cells

  • Neurocognitive insights in substance addiction

  • Current trends in neuroimaging and psychosis

  • Genetic causes of autism

  • Pharmacological challenges for understanding affective and stress-related disorders

Furthermore, the educational updates at the congress will deal with the impact of current social, economic and cultural changes on mental health care (e.g. neuroethics, effects of migration etc.).

For further information about the provisional scientific programme, please visit the ECNP website: http://www.ecnp.eu.

The exciting scientific programme along with the congress site Barcelona, one of the most beautiful cities in Southern Europe with an amazing cultural energy and a passion for progress, will make this congress an outstanding and unforgettable event.

We hope you will find this meeting of interest and a valuable source of information for spreading the spirit of scientific adventure and
'/>"/>

Contact: Sonja Mak
s.mak@update.europe.at
0043-140-55734
European College of Neuropsychopharmacology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. APIC Statement on April 16 Congressional Hearing on Healthcare-Associated Infections: A Preventable Epidemic
2. Youth and Adults Throughout Illinois Urge Governor Blagojevich and Congress: Invest Our Tax Dollars Wisely
3. Joint Center to Focus on Issues of Health Equity During Congressional Black Caucus Spring Health Braintrust
4. Elder Falls Bill Passes Congress, Heads to President
5. Pro Football Hall of Fame Member Jim Kelly Urges Congress to Approve the Newborn Screening Saves Lives Act
6. Kidney Community Gathers on Capitol Hill to Ask Congress to Support Legislation for Increased Kidney Care Education, Updates for Kidney Dialysis Benefit
7. Telecommunications Carriers Respond To Congress Declaration of April as National 9-1-1 Education Month
8. Front Line Caregivers from 16 States to Visit Capitol Hill to Urge State Congressional Delegation to Reject Medicare Cuts that Could Threaten Quality Care in Nations Nursing Homes
9. Will Congress Do More for HIV Prevention?
10. Ukiah Home Oxygen Therapy Patients and Physicians Meet with Congressman Mike Thompson to Share Benefits of Quality Home Oxygen Care
11. FEW Announces Legislative Goals for Remainder of 110th Congress; Delivers Fact Sheets to Legislators
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)...clinical trial results could lead to availability ...reatment for deep lines and wrinkles by 2009. , ...y 24, 2008 -- Gel-Del Technologies , a St. Paul, ...d that it has concluded clinical trials of Cosmeta...ials say holds potential to be a more effective al...
(Date:7/23/2008)... the Financing Needs of European and A... YORK, July 24 /PRNewswire/ -- Paul Capital Partne...en promoted to Partner. Based in Paul,Capital,s Lo...ng,evaluating and negotiating European and Asian ...apital Healthcare funds., "Since he joined Paul C...
(Date:7/23/2008)...out-of-state intended parents, SAN RAMON, Calif.,...reme Court decision to allow gay couples to marry ...ence Center of the Bay Area (RSC), one of,the stat...nd lesbians for,infertility treatment., "Californ...C,s,long-held views that procreation is a natural ...
(Date:7/23/2008)...Call/ -- The Hanover Insurance Group,a leading su...announced it,is prepared to respond to claims resu...ugh southern Texas today., (Logo: http://www.new... are deeply concerned about individuals and busine...ent of The Hanover,s Central Region. "Our,staff is...
Breaking Medicine News(10 mins):Health News:Clinical Trial Concluded For New Wrinkle Treatment 2Health News:Clinical Trial Concluded For New Wrinkle Treatment 3Health News:Paul Capital Partners Promotes Ken Macleod To Partner 2Health News:Paul Capital Partners Promotes Ken Macleod To Partner 3Health News:California Supreme Court Gay-Marriage Ruling Reinforces Top Bay Area Fertility Specialists' Support for Same-Sex Couples 2Health News:The Hanover Ready to Serve Policyholders Impacted by Hurricane Dolly 2
...der women suffering from chronic cytomegalovirus//...in life) were found to have more than triple the r... infection. This was reported in the Journal of th...time an association between CMV and frailty syndro...
...echnique to increase blood flow to the heart// tha...o increase 5 years of patients’ life than the coro...dical Center, US, have found that patients who had...eries have more life span when they undergo arteri...
...s with the help of seroquel is effective//, says a...bling mental illness. Some of the symptoms suffere...d, feelings of being persecuted, becoming withdraw...a can be treated symptomatically, but only one in ...
...od lower risk// of stroke.This link between childh... in a very interesting study published in the jour...n adults is not just due to exposure to risk facto...lated event over an entire lifetime. Previous stud...
Other Medicine News:Health News:Association between childhood diet and stroke 2
(Date:7/23/2008)...uly 23 /- Sound Pharmaceuticals (SPI)... with the FDA for the clinical,testing of a propri...,chemotherapy induced hearing loss or ototoxicity....ll be tested in advanced stage lung cancer,and hea...d chemotherapy.,This marks the second development ...
(Date:7/23/2008)...SCO, July 23 /- InCode BioPharmaceuti...oday announced preclinical test,results demonstrat... for,the treatment of the rare chronic blood disor... complete results will be presented at the XXII,In...and, September 28,2008., The only treatment curr...
(Date:7/22/2008)...fficacy results from a multi-center 293-patient Eu...onto Stock Exchange Symbol: CYT, MONTREAL, July 2...s,Inc., the global leader in cryotherapy products ... results previously presented from three,European ...ctic Front(R),were published earlier today in the...
(Date:7/22/2008)...strates Feasibility and Efficacy of Treating Patie...ncer, SAN FRANCISCO, and YONGIN-SI, South Korea, ...sco, CA and Ottawa, Ontario), and its South,Korean...ovel findings from,a Phase I clinical trial of its...hat the product was well-tolerated and resulted in...
Breaking Medicine Technology:Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4APHA Says Investing in Healthy People and Communities Can Help Create a Healthy Economy 10240 1APHA Says Investing in Healthy People and Communities Can Help Create a Healthy Economy 10240 2Cellix Ltd Launches the First Semi Automated High Throughput Cell Adhesion Assay Platform 2770 1Cellix Ltd Launches the First Semi Automated High Throughput Cell Adhesion Assay Platform 2770 2New study finds resistant organisms at core of soft contact lens corneal infections 10235 1New study finds resistant organisms at core of soft contact lens corneal infections 10235 2Alexion Pharmaceuticals Invites You to Participate in its Fourth Quarter and Full Year 2007 Results Conference Call and Web Cast 2766 1
...ne, the U.S.-based subsidiary of,Pharmexa A/S, pre...gram today at the Influenza Conference entitled, "...Toronto, Ontario, Canada. The,data show that a "un...immune responses can protect transgenic mice again..., HORSOLM, Denmark, June 21, 2007-Pharmexa-Epimmun...
... June 21, 2007 - “In anaplastic,astrocytoma,...erior,to temozolomide,” Prof. Albert Wong, M...nted on the international Phase,IIb study with the...by Antisense Pharma. Prof. Wong discussed the resu...on central nervous system tumors,at the 43rd Annua...
Other Medicine Technology:Pharmexa A/S (DK) - Pharmexa presents data from influenza program 2Antisense Pharma: Promising Phase IIb Results of Targeted Therapy,with AP 12009 in Recurrent Anaplastic Astrocytoma 2Antisense Pharma: Promising Phase IIb Results of Targeted Therapy,with AP 12009 in Recurrent Anaplastic Astrocytoma 3Antisense Pharma: Promising Phase IIb Results of Targeted Therapy,with AP 12009 in Recurrent Anaplastic Astrocytoma 4
...es, the Advantage Smart Table goes up to 6 inches ...h to accommodate all open procedures. Controlled w...sitions for various surgeons and procedures. One b...to level. The simple unidirectional set-up of the ...
Inquire
Liquichek Elevated CRP Control is a liquid assayed serum control with elevated levels of C-Reactive Protein.
Liquichek Cardiac Markers Plus Control is a premium, comprehensive cardiac assessment control with many analytes and long stability.
Medicine Products: